2 ms·
Should the state create incentives for future drugs tomorrow, or enable generic drugs that allow poor people to survive today. Its a moral question, with fairly
by belorn 12y ago
Should the state create incentives for future drugs tomorrow, or enable generic drugs that allow poor people to survive today. Its a moral question, with fairly easy statements: Deny cheaper drugs, and some people die today which could be saved. Allow cheaper drugs, and less future investments might happen outside state sponsored research.
Over 30 Billion Dollars, about 1/3 of all biomedical research funding in the US is paid from tax money. The 2/3 that is left is divided between non-profit, hospitals, and drug companies. The one asking the state to grant patents is the drug companies, which is where the VC part kicks in.
It is worth talking about if this is a good idea. The sacrifice need to be talked about, openly, and admitted. It would be good to see research that show how the world would look like if that part of the 2/3 which is paid from drug companies would shrink. Maybe ask, experiment and test what happens if the incentive model could use other incentives than state granted patents. Calculate how much wealth society would gain, and could be reinvested into research, if poor people with work debilitating sicknesses was allowed to buy generic and get treated.
- jimbokun 12y agoProbably be cheaper in the long run for the U.S. government to pay all $90B (according to your figure) for all drug research, end drug patents, and non-exclusively license the resulting drug research at a nominal fee to manufacturers.